| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |